| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/17/2010 | CN101647816A Bionic enzymatic hydrolysate for animal skins and application thereof |
| 02/17/2010 | CN101647815A Bionic enzymatic product of animal medicament and application thereof |
| 02/17/2010 | CN101647814A Bionic enzymatic product of horns and application thereof |
| 02/17/2010 | CN101647813A Bionic enzymatic hydrolysate for animal medicaments and application thereof |
| 02/17/2010 | CN101647812A Method for extracting deer antler extract continuously and quickly at normal temperature |
| 02/17/2010 | CN101647811A Bionic enzymatic product of animal medicament and application thereof |
| 02/17/2010 | CN100589812C Plant worms mycelium extracat fraction and composition for oral intake |
| 02/17/2010 | CN100589811C Eel oil extract and its extraction process and blood fat reducing health product |
| 02/17/2010 | CN100589810C A white blood cell antibiotic activity substance from siam alligator and method for making same |
| 02/16/2010 | US7662923 Modified vitamin K-dependent polypeptides |
| 02/16/2010 | US7662768 Transdifferentiation of pancreatic acinar cells |
| 02/16/2010 | US7662411 Process for removal of solvent and detergent from plasma |
| 02/16/2010 | US7662401 administering combination of extract of Vitreoscilla filiformis bacteria and lycopene as antioxidant for limiting and/or eliminating objectionable body odors caused by skin lipid oxidation; catalase or peroxidase activity |
| 02/16/2010 | US7662398 Microorganisms for therapy |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662371 Composition for lowering the concentration of intestinal pathogenic peptides |
| 02/16/2010 | CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/16/2010 | CA2220433C Il-6 activity inhibitor |
| 02/16/2010 | CA2201108C Prolonged preservation of blood platelets |
| 02/16/2010 | CA2154231C Process for the preparation of a c1-esterase inhibitor concentrate (c1-inh) and concentrate thus obtained, for therapeutic uses |
| 02/11/2010 | WO2010017216A2 Mesenchymal stromal cell populations and methods of isolating and using same |
| 02/11/2010 | WO2010016942A1 Composition for a tissue repair implant and methods of making the same |
| 02/11/2010 | WO2010016083A1 Use of isolated mature adipocytes in regenerative medicine for the reconstruction and reparation of tissues |
| 02/11/2010 | WO2010015929A2 Uses of mesenchymal stem cells |
| 02/11/2010 | WO2010015580A1 Production of beadlets comprising probiotic compounds |
| 02/11/2010 | WO2009116088A4 Stem cell composition for inducing transplant tolerance |
| 02/11/2010 | WO2009044163A3 Anti-bacteria compositions |
| 02/11/2010 | US20100035819 Method of promoting skin collagen production |
| 02/11/2010 | US20100035324 Apparatus for the regeneration of human tissue |
| 02/11/2010 | US20100034909 Pharmaceutical composition for treating rotavirus and/or respiratory syncytial virus infection and method for preparing the same |
| 02/11/2010 | US20100034897 Method for Removal or Inactivation of Heparin |
| 02/11/2010 | US20100034892 Treatment for bone formation disorders by growth factor delivery |
| 02/11/2010 | US20100034877 Use of lactobacillus for treatment of virus infections |
| 02/11/2010 | US20100034866 Fused stem cells useful for the treatment of diabetes and methods thereof |
| 02/11/2010 | US20100034849 Recombinant Bicistronic Flavivirus Vectors |
| 02/11/2010 | US20100034832 Methods for manipulating stem cells |
| 02/11/2010 | US20100034794 Endothelial progenitor cell compositions and neovascularization |
| 02/11/2010 | US20100034793 Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood |
| 02/11/2010 | US20100034791 Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery |
| 02/11/2010 | US20100034790 Use of materials for treatment of central nervous system lesions |
| 02/11/2010 | US20100034788 Method for diagnosing and treating bone-related diseases |
| 02/11/2010 | US20100034787 Composition and methods for promoting hair growth |
| 02/11/2010 | US20100034786 Use of PI3K M-TOR and Akt Inhibitors to Induce FOXP3 Expression and Generate Regulatory T Cells |
| 02/11/2010 | US20100034785 Differentiation of Pluripotent Cells into Primary Germ Layer Progenitors |
| 02/11/2010 | US20100034784 inhibiting neuronal death, inducing proliferation and differentiation of a neuronal progenitor cell into a neuron and increasing the number of neurons, in humans |
| 02/11/2010 | US20100034783 Medical kit and using method thereof |
| 02/11/2010 | US20100034782 Methods of Using Anti-Thymocyte Globulin and Related Agents |
| 02/11/2010 | US20100034781 Oxysterol Compounds and the Hedgehog Pathway |
| 02/11/2010 | US20100034780 Tumor antigen peptide derived from amacr |
| 02/11/2010 | US20100034778 Stem cells |
| 02/11/2010 | US20100034777 Method for Regulating Protein Function in Cells In Vivo Using Synthetic Small Molecules |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | US20100034775 RECOMBINANT ADENOVIRUS COMPRISING RECOMBINANT khp53 GENE AND THE PREPARATION METHOD AND USES THEREOF |
| 02/11/2010 | US20100034772 Compositions and methods for immunotherapy |
| 02/11/2010 | US20100034768 Composition and method for treatment of insect bites |
| 02/11/2010 | DE202008016879U1 Antidiarrhoikum Antidiarrheal |
| 02/11/2010 | CA2736353A1 Mesenchymal stromal cell populations and methods of isolating and using same |
| 02/11/2010 | CA2733273A1 Composition for a tissue repair implant and methods of making the same |
| 02/11/2010 | CA2732908A1 Uses of mesenchymal stem cells |
| 02/10/2010 | EP2151245A1 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 02/10/2010 | EP2151243A2 Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations |
| 02/10/2010 | EP2150616A2 Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety |
| 02/10/2010 | EP2150613A1 Mutant reoviruses and methods of making and using |
| 02/10/2010 | EP2150611A1 Novel thymic cellular populations and uses thereof |
| 02/10/2010 | EP1537204B1 Granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 02/10/2010 | CN101646445A Probiotics for reduction of risk of obesity |
| 02/10/2010 | CN101646444A Prophylactic and/or therapeutic agent for functional dyspepsia |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN101642475A Microbial preparation for preventing and treating mastitis and applications thereof |
| 02/10/2010 | CN101642474A Method for producing organic selenium ant powder |
| 02/10/2010 | CN101642473A Brain-nourishing intelligence-benefiting oral liquid and preparation method thereof |
| 02/10/2010 | CN101642472A Oviductus ranae soft capsule and manufacturing process thereof |
| 02/10/2010 | CN101642471A Pilose antler activity comprehensive processing and production technology |
| 02/10/2010 | CN101642470A Deer product effervescent tablets prepared by microshearing-additive interaction technology and preparation method thereof |
| 02/10/2010 | CN101642469A Application of umbilical cord mesenchymal stem cells (MSCs) in the acute myocardial infarction cell transplantation therapy |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659121 culturing human salivary gland cells in vitro to obtain human stem cells which are nestin-positive and albumin-positive, differentiating the stem cells by culture in vitro to induce insulin-positive cells; regenerative therapy; transplant rejection |
| 02/09/2010 | US7659118 Multipotent adult stem cells |
| 02/09/2010 | US7659117 Immunostimulatory fusion proteins comprising polypeptide antigen for generating protective DC-induced T-cell-mediated immune responses; metastatic cancers |
| 02/09/2010 | US7659115 Nucleic acid encoding human transductin-1 polypeptide |
| 02/09/2010 | US7659103 Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle |
| 02/09/2010 | US7658951 Method of improving cardiac function of a diseased heart |
| 02/09/2010 | US7658950 synovial fluids collected, purified and freeze dried for use as replacement fluid in joints; shelf life, sterility; e.g. in horses, synovial fluid from slaughterhouses used in e.g. race horses |
| 02/09/2010 | US7658915 Selected cell delivery for heart failure |
| 02/09/2010 | US7658768 Calcium sulfate hemihydrate, accelerant (calcium sulfate dihydrate), plasticizing material, mixing solution, demineralized bone matrix, water; filler for voids and/or defects defined by bone |
| 02/09/2010 | CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 02/09/2010 | CA2445558C Biocompatible scaffolds with tissue fragments |
| 02/09/2010 | CA2370714C Bacterial ghosts as carrier and targeting vehicles |
| 02/09/2010 | CA2334222C Insulin supplemented infant formula |
| 02/09/2010 | CA2286614C Plant extracts for the treatment of increased bone resorption |
| 02/09/2010 | CA2205910C Plasmids suitable for il-2 expression |
| 02/09/2010 | CA2196315C Treatment of cancer using hsv mutant |
| 02/09/2010 | CA2150933C Glaucoma treatment |
| 02/04/2010 | WO2010014949A2 Compositions comprising hepatocyte-like cells and uses thereof |
| 02/04/2010 | WO2010014043A1 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same |
| 02/04/2010 | WO2010014021A1 Tissue scaffolds derived from forestomach extracellular matrix |
| 02/04/2010 | WO2010013934A2 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same |